Citalopram Hydrobromide
Brand name: Citalopram Hbr
Rank #379 of 500 drugs by total cost
$25.3M
Total Cost
2,778,255
Total Claims
$25.3M
Total Cost
67,862
Prescribers
$9
Cost per Claim
428,177
Beneficiaries
5,591,923
30-Day Fills
$373
Avg Cost/Provider
41
Avg Claims/Provider
About Citalopram Hydrobromide
Citalopram Hydrobromide (sold as Citalopram Hbr) was prescribed 2,778,255 times by 67,862 Medicare Part D providers in 2023, costing the program $25.3M. At $9 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 376 | Amitriptyline Hcl (Amitriptyline Hcl) | $25.8M | 1,295,043 |
| 377 | Tezepelumab-Ekko (Tezspire) | $25.6M | 5,900 |
| 378 | Ponatinib Hcl (Iclusig) | $25.6M | 1,209 |
| 379 | Citalopram Hydrobromide (Citalopram Hbr) | $25.3M | 2,778,255 |
| 380 | Amoxicillin/Potassium Clav (Amoxicillin-Clavulanate Potass) | $25.3M | 2,207,997 |
| 381 | Infliximab (Remicade) | $25.3M | 3,457 |
| 382 | Glimepiride (Glimepiride) | $25.3M | 1,885,737 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology